Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized, blinded, placebo-controlled poliovirus challenge study of oral V-073 in healthy adults receiving mOPV1
2011-004804-38Phase 2Completed
- Sponsor
- ViroDefense Inc
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in poliomyelitis comparing V-073 with Placebo (2 arms). Primary endpoints: Effect of V-073 on poliovirus serotype 1 stool excretion and Pharmacokinetic profile of V-073. Started Oct 2011; status: completed.
02
Drugs
pocapavir
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on 2011-004804-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004804-38.